EHMT2 and neoplasm: Several EHMT2 inhibitors have demonstrated good anti-tumor activity by preventing cancer cell proliferation and inducing apoptosis in many types of tumors, such as T lymphoblastic leukemia cells, bladder cancer, glioma tumor, renal cancer, and so on 10, 19-21.